Biotech Funding, Vaccine, and Policy Shifts
Kilder
- STAT: STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early
- BioPharma Dive: Moderna, Merck shares fall on eagerly anticipated cancer vaccine results - BioPharma Dive
- STAT: STAT+: Treasury proposes major restrictions to U.S. investment in Chinese biotech sector
- Americanactionforum: New COINS Act Regulations Restricting Biotechnology Investment Leave Critical Questions Unanswered - The American Action Forum
- Politico: Proposed rules target US-China biotech ties - Politico
- Endpoints: Pathos raises $237M at $3B valuation, signs Bristol Myers neuro partnership
- Endpoints: Windward Bio files for Nasdaq IPO to fund China-derived assets and in-house R&D
- BioPharma Dive: This week in charts: a big year for RNAi developers
- NTB: Ebolavaksine testes i Kongo
- wikimedia: Photo by CDC Global / Wikimedia Commons / CC BY 2.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.